{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:17:05Z","timestamp":1791091025461,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.juro.2013.05.062","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T12:36:15Z","timestamp":1369917375000},"page":"1320-1327","source":"Crossref","is-referenced-by-count":141,"title":["Urodynamics and Safety of the \u03b2\n                    <sub>3<\/sub>\n                    -Adrenoceptor Agonist Mirabegron in Males with Lower Urinary Tract Symptoms and Bladder Outlet Obstruction"],"prefix":"10.1097","volume":"190","author":[{"given":"Victor W.","family":"Nitti","sequence":"first","affiliation":[{"name":"Department of Urology, New York University Langone Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Department of Urology, Iowa Clinic, West Des Moines, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Mitcheson","sequence":"additional","affiliation":[{"name":"St. Elizabeth's Medical Center, Brighton, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"He","sequence":"additional","affiliation":[{"name":"Global Data Sciences, Astellas Pharma Global Development, Global Medical Science, Northbrook, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allam","family":"Fakhoury","sequence":"additional","affiliation":[{"name":"Global Development Project Leader, Astellas Pharma Global Development, Global Medical Science, Northbrook, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Martin","sequence":"additional","affiliation":[{"name":"Global Medical Science, Astellas Pharma Global Development, Global Medical Science, Northbrook, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.05.062_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2013.05.062_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14740338.2011.542146","article-title":"Mirabegron: a safety review","volume":"10","author":"Tyagi","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.juro.2013.05.062_bib3","unstructured":"Dmochowski RR: Bladder outlet obstruction: etiology and evaluation. Rev Urol, suppl., 2005; 7: S3."},{"key":"10.1016\/j.juro.2013.05.062_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1742-1241.2010.02611.x","article-title":"Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review","volume":"65","author":"Kaplan","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.juro.2013.05.062_bib5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.juro.2009.06.051","article-title":"Do oral antimuscarinic drugs carry an increased risk of acute urinary retention?","volume":"182","author":"Mart\u00edn-Merino","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.062_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.eururo.2004.11.011","article-title":"Low incidence of acute urinary retention in the general male population: the triumph project","volume":"47","author":"Verhamme","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.05.062_bib7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.106.115840","article-title":"Effect of (R)-2-(2-aminothiazol-4-yl)-4\u2032-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective \u03b23-adrenoceptor agonist, on bladder function","volume":"321","author":"Takasu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.juro.2013.05.062_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/nau.20420","article-title":"\u03b23-Adrenoceptors in urinary bladder","volume":"26","author":"Yamaguchi","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2013.05.062_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1756287209103937","article-title":"Prospective pharmacologic therapies for the overactive bladder","volume":"1","author":"Andersson","year":"2009","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.juro.2013.05.062_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/jpet.108.138651","article-title":"Effects of the \u03b23-adrenergic receptor agonist disodium 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole -2,2-dicarboxylate (CL-316243) on bladder micturition reflex in spontaneously hypertensive rats","volume":"326","author":"Leon","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.juro.2013.05.062_bib11","first-page":"713","article-title":"Mirabegron, a \u03b23-adrenoceptor agonist for the potential treatment of\u00a0urinary frequency, urinary incontinence or urgency associated with overactive bladder","volume":"13","author":"Tyagi","year":"2010","journal-title":"IDrugs"},{"key":"10.1016\/j.juro.2013.05.062_bib12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.juro.2012.10.017","article-title":"Results of a randomized phase III trial of mirabegron in patients with overactive bladder","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.062_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2012.10.016","article-title":"Efficacy\u00a0and tolerability of mirabegron, a \u03b2(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial","volume":"63","author":"Khullar","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.05.062_bib14","doi-asserted-by":"crossref","unstructured":"Herschorn S, Barkin J, Castro-Diaz D et\u00a0al: A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the \u03b23 adrenoceptor agonist, mirabegron in patients with symptoms of overactive bladder. Urology, Epub ahead of print June 12, 2013.","DOI":"10.1016\/j.urology.2013.02.077"},{"key":"10.1016\/j.juro.2013.05.062_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"Sch\u00e4fer","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2013.05.062_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.1999.00121.x","article-title":"Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function","volume":"84","author":"Abrams","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.05.062_bib17","unstructured":"Bristol Urological Institute: International Consultation on Incontinence Modular Questionnaire (ICIQ). Available at http:\/\/www.iciq.net\/ICIQ.MLUTS.html. Accessed October 31, 2012."},{"key":"10.1016\/j.juro.2013.05.062_bib18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","article-title":"A new questionnaire to assess the quality of life of urinary incontinent women","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.juro.2013.05.062_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.062_bib20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/01.ju.0000181823.33224.a0","article-title":"Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"174","author":"Kaplan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.05.062_bib21","first-page":"S14","article-title":"Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction","volume":"7","author":"Nitti","year":"2005","journal-title":"Rev Urol, suppl"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713045151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713045151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.05.062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T23:26:34Z","timestamp":1651188394000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.05.062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1016\/j.juro.2013.05.062"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.05.062","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718016323.793478118","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}